Clinical and Metabolic Effects of Medroxyprogesterone Acetate and Ethinyl Estradiol Plus Drospirenone in Women with Polycystic Ovary Syndrome

    July 2008 in “ International Journal of Gynecology & Obstetrics ”
    Suna Özdemir, Hüseyin Görkemli, Kazım Gezginç … Aysel Kıyıcı
    Studysummary This study found that medroxyprogesterone acetate treatment in women with PCOS reduced hyperandrogenism-related hormonal levels and improved skin conditions without affecting lipid or carbohydrate metabolism.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Polycystic Ovary Syndrome: A Comprehensive Review Journal Of Endocrinology, Metabolism And Diabetes Of South Africa · 2009
    2. Pharmacologic Therapy of Polycystic Ovary Syndrome Clinical Obstetrics and Gynecology · 2007
    3. Diagnosis of Hyperandrogenism: Clinical Criteria Best Practice & Research Clinical Endocrinology & Metabolism · 2006
    4. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004

    Related research 5

    1. Current Aspects of Polycystic Ovary Syndrome: A Literature Review Revista Da Associacao Medica Brasileira · 2016
    2. The Relationship Between Acne and Other Hyperandrogenism Signs Journal of skin and stem cell · 2016
    3. Effects of Hyperandrogenism and High Body Mass Index on Acne Severity in Women PubMed · 2014
    4. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    5. The Diagnosis of Polycystic Ovary Syndrome in Adolescents American Journal of Obstetrics and Gynecology · 2010